机译:肠肠静止胰岛素:CaCO-2和Caco-2 / HT29共培养单层的应用以及大鼠内尿道滴注
Univ Copenhagen Fac Hlth &
Med Sci Dept Pharm DK-2100 Copenhagen Denmark;
Sanofi Aventis Deutschland GmbH Diabet Div Res &
Dev K703 D-65926 Frankfurt Germany;
Sanofi Aventis Deutschland GmbH Diabet Div Res &
Dev K703 D-65926 Frankfurt Germany;
Sanofi Aventis Deutschland GmbH Diabet Div Res &
Dev K703 D-65926 Frankfurt Germany;
Univ Copenhagen Fac Hlth &
Med Sci Bioneer FARMA DK-2100 Copenhagen Denmark;
Univ Copenhagen Fac Hlth &
Med Sci Bioneer FARMA DK-2100 Copenhagen Denmark;
Univ Copenhagen Fac Hlth &
Med Sci Dept Pharm DK-2100 Copenhagen Denmark;
Univ Copenhagen Fac Hlth &
Med Sci Dept Pharm DK-2100 Copenhagen Denmark;
Insulin; Intestinal barrier; Self-emulsifying drug delivery systems; Caco-2 monolayers; Caco-2/HT29-MTX co-culture monolayers; Intra-jejunal administration; Monoacyl phosphatidylcholine;
机译:肠肠静止胰岛素:CaCO-2和Caco-2 / HT29共培养单层的应用以及大鼠内尿道滴注
机译:黄ical苷使用新型体外模型的吸收过程的药代动力学概况:细胞色素P450 3A4诱导的Caco-2细胞单层与大鼠肠道冲洗液的结合
机译:甲氨蝶呤可以减少甲氨蝶呤跨Caco-2细胞单层的跨细胞渗透,并减少其在大鼠中的肠道吸收。
机译:具有吸收性CaCo-2细胞的肠床HT29和M样细胞的组合预测含胰岛素的纳米颗粒的口服吸收
机译:丁酸比例对乙酸和丙酸生理浓度的增加对Caco-2细胞肠完整性和IL-8分泌的影响
机译:益生菌和Caco-2:HT29–MTX上皮共培养物对山羊牛奶中碳水化合物的代谢及其对肠屏障完整性的影响
机译:人肠上皮细胞单层在人类中口服吸毒预测的应用作为CaCo-2细胞单层的优越替代品